Suppr超能文献

用重组 PfEMP1 结构域免疫可诱导针对恶性疟原虫的功能性红细胞花环抑制和吞噬诱导抗体。

Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.

机构信息

Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.

出版信息

PLoS One. 2011 Jan 31;6(1):e16414. doi: 10.1371/journal.pone.0016414.

Abstract

BACKGROUND

Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria.

METHODOLOGY/FINDINGS: We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 µg/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 µg/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 µg/ml). Antibodies to the N-terminal region (NTS-DBL1α) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains.

CONCLUSIONS/SIGNIFICANCE: These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites.

摘要

背景

成缗现象是恶性疟原虫的一种毒力因子,与危及生命的疟疾发病机制有关。当寄生虫表面的疟原虫红细胞膜蛋白 1(PfEMP1)与未感染的红细胞上的人类受体结合时,就会发生成缗现象。PfEMP1 是一种疫苗的潜在靶点,可以诱导抗体抑制成缗作用,预防严重疟疾。

方法/结果:我们通过用大肠杆菌表达的重组蛋白免疫兔子,研究了介导成缗的 PfEMP1 变体(来自 R29 寄生虫株的 ITvar9/R29var1)的六个细胞外结构域的疫苗潜力。用活的感染红细胞测试针对每个结构域产生的抗体的表面荧光、成缗抑制和吞噬诱导。针对 PfEMP1 所有结构域的抗体都能在低浓度(总 IgG 浓度为 0.02-1.56 µg/ml)下识别活的感染红细胞表面。除第二个 Duffy 结合样区外,针对 PfEMP1 所有结构域的抗体都能抑制成缗(50%抑制浓度为 0.04-4 µg/ml),并且能够在低浓度(1.56-6.25 µg/ml)时调理并诱导感染红细胞的吞噬作用。针对 N 端区域(NTS-DBL1α)的抗体在所有测定中效果最佳。所有抗体均针对 R29 寄生虫株特异,对其他五个成缗株没有功能活性。

结论/意义:这些结果令人鼓舞,因为它们表明可以针对重组 PfEMP1 结构域产生有效的抗体,这些抗体可以抑制成缗作用并诱导感染红细胞的吞噬作用。然而,还需要进一步研究成缗机制和现场分离株的交叉反应性,以确定一组 PfEMP1 变体,这些变体可以诱导针对广泛的恶性疟原虫成缗寄生虫的功能性抗体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f1/3031562/b304812b9f9f/pone.0016414.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验